Manabu Tashiro, Department of Nephrology, Medical Director of Kawashima Hospital.
2007: Graduated from Yamanashi University Faculty of Medicine.
2017: Fukuoka University Graduate School Doctoral Program No.1649.
Work experience:
2010~2012: Assistant Professor, Division of Nephrology and Rheumatology, Department of Internal Medicine, Faculty of Medicine, Fukuoka University,
2013~2016: Graduate school, Division of Nephrology and Rheumatology, Department of Internal Medicine, Faculty of Medicine, Fukuoka University.
2017~: Kawashima hospital
Current and previous research interests:
Comparison of life prognosis in HD and HDF in hemodialysis patients;
Albumin leakage and life prognosis and symptoms;
Comparison of albumin leakage and alpha 1mg removal efficiency.
Memberships of professional societies and awards received:
The Japanese Society for Dialysis Therapy, number of members:18263;
The Japanese Society for Peritoneal Dialysis, number of members: 2700;
The Japanese Society of High-Performance Membranes for Blood Purification, number of members: 375.
Outstanding Presentation Award, The 25th Annual Meeting of the Japanese Society for Peritoneal Dialysis;
Outstanding Presentation Award, The 36th and 38th Annual Meeting of the Japanese Society of High-Performance Membranes for Blood Purification.
Manabu Tashiro, Department of Nephrology, Medical Director of Kawashima Hospital.
2007: Graduated from Yamanashi University Faculty of Medicine.
2017: Fukuoka University Graduate School Doctoral Program No.1649.
Work experience:
2010~2012: Assistant Professor, Division of Nephrology and Rheumatology, Department of Internal Medicine, Faculty of Medicine, Fukuoka University,
2013~2016: Graduate school, Division of Nephrology and Rheumatology, Department of Internal Medicine, Faculty of Medicine, Fukuoka University.
2017~: Kawashima hospital
Current and previous research interests:
Comparison of life prognosis in HD and HDF in hemodialysis patients;
Albumin leakage and life prognosis and symptoms;
Comparison of albumin leakage and alpha 1mg removal efficiency.
Memberships of professional societies and awards received:
The Japanese Society for Dialysis Therapy, number of members:18263;
The Japanese Society for Peritoneal Dialysis, number of members: 2700;
The Japanese Society of High-Performance Membranes for Blood Purification, number of members: 375.
Outstanding Presentation Award, The 25th Annual Meeting of the Japanese Society for Peritoneal Dialysis;
Outstanding Presentation Award, The 36th and 38th Annual Meeting of the Japanese Society of High-Performance Membranes for Blood Purification.